IP Library Granted Patent US 7,090,874
Granted Patent B2
US 7,090,874 · App. 10/752,643 · Granted Aug 15, 2006

Ligand for peroxisome proliferator-activated receptor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,090,874
App. No.
10/752,643
Granted
Aug 15, 2006
Kind
B2
Abstract

The object of the present invention is to provide PPARγ ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPARγ ligand as an active agent. The present invention relates to a ligand for peroxisome proliferator-activated receptor which comprises curcumin or its derivatives. The composition according to the present invention, which comprises the PPARγ ligand as an active agent is useful for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity.

Claims (4)

1. A method for reducing visceral fat, which comprises administering to a subject suffering from type-II diabetes mellitus, hyperinsulinemia, dyslipidemia, hypertension, and/or arteriosclerotic cardiovascular disease, a composition comprising at least one selected from the group consisting of curcumin and a curcuminoid as an active agent, with the intention of reducing visceral fat in said subject.

2. The method according to claim 1 , wherein said composition is in the form of a food or a drink.

3. The method according to claim 1 , wherein said composition is in the form of a pharmaceutical.

4. The method according to claim 1 , wherein said subject is a domestic animal or pet.

Assignments (1)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →